(Q34073723)

English

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

object named as

Leslie Citrome

1

0 references

author name string

Peter J Weiden

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Joseph P McEvoy

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Christoph U Correll

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Josephine Cucchiaro

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jay Hsu

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Antony Loebel

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

16 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

C N S Spectrums

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

330-339

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

copyright license

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

16 December 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Lurasidone in schizophrenia: new information about dosage and place in therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Past and present progress in the pharmacologic treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Strategies for dosing and switching antipsychotics for optimal clinical management.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Switching in the era of atypical antipsychotics. An updated review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

A rating scale for extrapyramidal side effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

How to examine patients using the Abnormal Involuntary Movement Scale.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

A rating scale for drug-induced akathisia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

5 July 2018

Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291300093X

21 January 2018

Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291300093X

21 January 2018

Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles

1 reference

https://api.crossref.org/works/10.1017%2FS109285291300093X

21 January 2018

Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients

1 reference

https://api.crossref.org/works/10.1017%2FS109285291300093X

21 January 2018

Real-life switching strategies with second-generation antipsychotics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4140225

28 October 2018

Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24330868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A depression rating scale for schizophrenics

1 reference

https://pubmed.ncbi.nlm.nih.gov/24330868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Switching antipsychotic medications

1 reference

https://pubmed.ncbi.nlm.nih.gov/24330868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: a 12-month, double-blind, noninferiority study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24330868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1017/S109285291300093X

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34073723&oldid=1863251118"